GVR Report cover Traumatic Brain Injury Assessment & Management Devices Market Size, Share & Trends Report

Traumatic Brain Injury Assessment & Management Devices Market Size, Share & Trends Analysis Report By Device (Imaging Devices, Monitoring Devices), By Technique, By End-use, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Feb, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68038-495-6
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 130

Report Overview

The global traumatic brain injury assessment and management devices market size was valued at USD 2.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.3% from 2021 to 2028. The increasing prevalence of traumatic brain injuries (TBIs), rising patients’ preference for minimally invasive procedures, and rising awareness regarding brain injuries are the major factors expected to fuel the market growth. In addition, the adoption of technologically advanced products and supportive government policies are few more factors contributing to the market growth. Traumatic brain injuries are permanent or temporary impairment to the brain that can be caused by a blow, bump, or shock to the skull. Major causes of TBIs include sports injuries, falls, gunshot wounds, domestic violence, and road traffic accidents.

U.S. traumatic brain injuries assessment and management devices market size, by device, 2016 - 2028 (USD Million)

As per the CDC, TBI is responsible for 2.8 million accidents and emergency department visits annually in the U.S. Furthermore, according to Stanford Children’s Health, over 3.5 million sports-related injuries are reported annually among children in the U.S. and around 21% of all are traumatic brain injuries. Thus, increasing TBIs due to sports injuries, road accidents, and assaults are anticipated to boost the demand for TBIs assessment and management devices during the forecast period.

Moreover, a rise in patients’ preference for minimally invasive neurosurgeries is expected to boost the market growth. Currently, most traumatic brain injuries can be primarily handled using minimally invasive devices, such as magnetic resonance imaging (MRI) or computed tomography (CT) scanning, transcranial doppler ultrasound, and endoscopy, to remove hematomas or contusions that occurred after the brain injury. Such specialized devices make it feasible for the neurosurgeons to reach deep lesions in the brain through a pinhole-sized opening in the skull without damaging surrounding tissue. Thus, the rising demand for minimally invasive neuro procedures owing to minimal pain, less chance of infection, and speedy recovery is expected to boost the demand for TBIs assessment and management devices.

Furthermore, the increasing number of initiatives and programs being undertaken by the governments of various countries about brain injuries are expected to fuel the market growth. For instance, the Brain Injury Association of America (BIAA) as an initiative toward traumatic brain injuries organizes a national public awareness campaign in the month of March every year to emphasize the importance of acknowledging the impact of brain injuries. The campaign ‘Change Your Mind’ 2018 to 2020 educates the public about the occurrence of brain injury and the needs of people with brain injuries and their families. Similarly, the Defense and Veterans Brain Injury Center (DVBIC) offers online education for both civilian and military providers to learn about traumatic brain injury in order to promote the best possible care for service members and veterans around the world. This growing awareness among people regarding the treatment to prevent the rate of TBIs is likely to boost the market growth.

Countries such as the U.S. and Canada have witnessed a high prevalence rate of traumatic brain injuries due to road accidents, sports injuries, and assaults. Gunshots or explosive blast exposure are common causes of TBIs in active-duty military personnel. For instance, as per the Defense and Veterans Brain Injury Center (DVBIC), between 2000 and late 2019, around 414,000 TBIs have been reported among U.S. military members. Similarly, according to the Brain Injury Association Waterloo-Wellington, over 11,000 individuals die due to TBIs every year in Canada, and over 6,000 become permanently disabled post-TBIs. Therefore, such a high prevalence rate of TBIs is estimated to boost the market growth over the forecast period.

Additionally, the increasing incidence of TBIs due to road accidents and falls in the developed and developing countries has driven the launch of technologically advanced products in the market. Market players are making constant efforts for introducing technologically advanced products in the market. For instance, BrainScope, a U.S.-based company, has been granted over USD 32 million of research contracts from the U.S. Department of Defense for the development of its BrainScope One device. It is EEG-based non-invasive technology that enables decision-making on the spot. In addition, in June 2019, Nihon Kohden launched a wireless Electroencephalogram (EEG) headset in the U.S. called VitalEEG to promptly assess brain activity in unconscious patients. This is anticipated to boost the demand for TBIs assessment and management devices during the forecast period.

Device Insights

The imaging devices segment dominated the market with a share of 54.04% in 2020. The imaging devices are further segmented into computed tomography (CT), magnetic resonance imaging (MRI) devices, X-ray, and others. Due to higher sensitivity, imaging devices are widely used to assess patients with a mild or severe traumatic brain injury. Thus, increasing applications in the diagnosis and staging of neurological diseases and disorders, particularly TBIs, are expected to fuel the segment growth. Based on the device, the market is segmented into imaging devices and monitoring devices.

The monitoring devices segment is expected to expand at the highest CAGR of 8.6% from 2021 to 2028 owing to the minimally invasive nature of these devices, increasing awareness, and improvement in healthcare facilities. Moreover, increasing patients’ preference for non-invasive procedures, the high preference among physicians for brain disease progression monitoring, and higher accuracy of these devices are expected to drive the segment during the forecast period.

Technique Insights

The intracranial pressure (ICP) monitoring segment dominated the market with a share of 54.61% in 2020. This method is considered to be a gold standard for the accurate measurement of intracranial pressure in patients with severe brain injury. Several studies have recommended that raised ICP is the common cause of death in patients with traumatic brain injury. Therefore, continuous ICP monitoring helps in keeping the pressure levels in the normal range and provides early and effective treatment. Thus, advantages offered by ICP monitoring and the increasing number of patients with TBIs are expected to boost the market growth. On the basis of technique, the market is segmented into ICP monitoring and partial pressure of oxygen in brain tissue (pBrO2).

The partial pressure of oxygen in the brain tissue (pBrO2) segment is expected to expand at the highest CAGR of 8.7% from 2021 to 2028. Continuous pBrO2 monitoring provides timely information about cerebral oxygen demand in patients suffering from traumatic brain injury. The pBrO2 monitoring systems provide continuous monitoring of partial pressure of oxygen in brain tissue, thus providing an early indication of hypoxic events. Thus, these factors are anticipated to boost the growth of the partial pressure of oxygen in brain tissue segment during the forecast period.

End-use Insights

The hospitals' segment dominated the market with a share of 43.17% in 2020 owing to the increase in the number of brain surgeries performed in hospitals as well as a surge in the prevalence of TBIs patients globally. Moreover, hospitals are well equipped with the technologically advanced devices that are being used by a professional neurologist, thus further boosting the segment growth. By end-use, the TBIs assessment and management devices market is segmented into hospitals, diagnostic centers, and others.

Japan traumatic brain injuries assessment and management devices market share, by end-use, 2020 (%)

The others' segment including ambulatory surgical centers, research centers, and emergency clinics is expected to expand at the highest CAGR of 8.7% from 2021 to 2028. This is attributed to numerous advantages offered by emergency clinics and ASCs such as shorter procedure time and same-day discharge as compared to hospitals. Furthermore, most brain surgeries can now be performed at ambulatory surgical centers as these procedures turn out to be more advanced and less invasive. Thus, the growth of the others' segment is majorly attributed to inexpensive and ongoing advancements in minimally invasive surgical techniques as well as shorter procedure time.

Regional Insights

North America dominated the market with a share of 52.73% in 2020. This is attributed to the presence of well-established healthcare facilities in the region, increasing government initiatives, awareness campaigns regarding brain injuries, and greater incidence of traumatic brain injuries in the region. For instance, as per the CDC, an expected 2.87 million individuals in the U.S. sustain brain injuries and 1.5 million Americans sustain a TBI annually. In the U.S., at present, more than 5.3 million people are living with a permanent TBI-related disability. These incidence rates involve around 2.5 million TBI-related emergency department visits, 288,000 hospitalizations, and 56,800 deaths. This is eventually contributing to the market growth in the region.

The Asia Pacific region is expected to expand at the highest CAGR of 9.9% from 2021 to 2028. This is attributed to factors such as growth in the aging population, rise in the number of people suffering from traumatic brain injuries, increasing incidence of road accidents, and violence. For instance, according to the Ministry of Road Transport and Highways, Government of India, around 4.5 million people were injured in road accidents in 2016. This number has increased by 25.6% from 2007 to 2017. Additionally, growing patient affordability has resulted in a significant number of interventional procedures in the Asia Pacific region.

Key Companies & Market Share Insights

Companies are focusing on research and development to develop technologically advanced products to gain a competitive edge. For instance, in January 2019, Oculogica Inc. received the U.S. FDA request for the marketing of the EyeBOX device. This device uses eye-tracking to help in the diagnosis of patients with suspected concussions in a 4-minute test.

Moreover, key companies are adopting various strategies, such as product launches, mergers & acquisitions, partnerships, and geographical expansion, to strengthen their foothold in the market. For instance, in September 2019, Integra LifeSciences completed the acquisition of Rebound Therapeutics, a manufacturer of disposable medical devices. With this acquisition, the company developed new products and a minimally invasive platform for neurosurgery. Such strategic initiatives are expected to increase the market share and revenue of the companies. Some prominent players in the global traumatic brain injury assessment and management devices market include:

  • BrainScope Company, Inc.

  • Neural Analytics, Inc.

  • Advanced Brain Monitoring Inc.

  • Natus Medical, Inc.

  • Integra Lifesciences

  • BioDirection, Inc.

  • Nihon Kohden Corporation

  • Compumedics Ltd.

  • InfraScan, Inc.

  • Oculogica

  • Raumedic AG

Traumatic Brain Injury Assessment And Management Devices Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 3.2 billion

Revenue forecast in 2028

USD 5.5 billion

Growth Rate

CAGR of 8.3% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Device, technique, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Colombia; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

BioDirection, Inc.; BrainScope Company, Inc.; Neural Analytics, Inc.; Compumedics Ltd.; Integra LifeSciences; Natus Medical, Inc.

Customization scope

Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global traumatic brain injury assessment and management devices market report on the basis of device, technique, end-use, and region:

  • Device Outlook (Revenue, USD Million, 2016 - 2028)

    • Imaging Devices

      • Magnetic Resonance Imaging (MRI) Devices

      • X-ray

      • Computed Tomography

      • Others

    • Monitoring Devices

  • Technique Outlook (Revenue, USD Million, 2016 - 2028)

    • Intracranial Pressure (ICP) Monitoring

    • Partial Pressure of Oxygen in Brain Tissue (pBrO2)

  • End-use Outlook (Revenue, USD Million, 2016 - 2028)

    • Hospitals

    • Diagnostic Centers

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.